Recombinant BCG Overexpressing a STING Agonist Elicits Trained Immunity and Improved Antitumor Efficacy in Non-Muscle Invasive Bladder
doi 10.1101/2020.04.25.061531
Full Text
Open PDFAbstract
Available in full text
Date
April 25, 2020
Authors
Publisher
Cold Spring Harbor Laboratory